{
    "nct_id": "NCT03307044",
    "official_title": "Fractional CO2 Laser Therapy for Survivors of Breast Malignancies",
    "inclusion_criteria": "* Women with non-metastatic breast cancer with any hormone receptor and Her 2 neu status who have completed surgery, chemotherapy, and radiation and are currently on endocrine therapy, single agent Herceptin, or observation\n* Symptoms of urogenital atrophy including dyspareunia or vaginal dryness\nHealthy volunteers allowed\nMust be FEMALE",
    "exclusion_criteria": "* Patients with metastatic breast cancer\n* Vaginal stenosis which would not allow vaginal probe to be placed (based on physician exam)\n* Active genital infection at the time of enrollment (if present initially, can be treated and then patient can be re-evaluated for eligibility)\n* Pelvic organ prolapse greater than stage II\n* Prior reconstructive pelvic surgery involving mesh\n* Hormone replacement therapy, vaginal estrogen therapy, DHEA, or biosynthetics within 6 weeks prior to enrollment",
    "miscellaneous_criteria": ""
}